Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000351434

Medchemexpress LLC Kras inhibitor-10 | 2578876-75-0 | 99.9% | 519.63 | 50 MG
SDP

Catalog No. 5000351434
Encompass_Preferred

KRAS inhibitor-10 is a tetrahydroisoquinoline compound that selectively and effectively inhibits RAS proteins, particularly KRAS proteins. It acts as an orally active anti-cancer agent, useful for various cancer research, including studies on pancreatic cancer, breast cancer, multiple myeloma, leukemia, and lung cancer.

  • Selectively and effectively inhibits RAS proteins, particularly KRAS proteins
  • Orally active anti-cancer agent
  • Utilized for cancer research
  • Exhibits antiproliferative effects in KRas mutant tumor cells
  • Shows significant oral anti-tumor activities in vivo
  • Safe and well-tolerated in bearing mice

Catalog No. 50-003-51434 Supplier Medchemexpress LLC Supplier No. HY13829550MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

KRAS inhibitor-10 is a tetrahydroisoquinoline compound that selectively and effectively inhibits RAS proteins, particularly KRAS proteins. It acts as an orally active anti-cancer agent, useful for various cancer research, including studies on pancreatic cancer, breast cancer, multiple myeloma, leukemia, and lung cancer.

  • Selectively and effectively inhibits RAS proteins, particularly KRAS proteins
  • Orally active anti-cancer agent
  • Utilized for cancer research
  • Exhibits antiproliferative effects in KRas mutant tumor cells
  • Shows significant oral anti-tumor activities in vivo
  • Safe and well-tolerated in bearing mice

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.